The MHC in human bone marrow allotransplantation

Area of Science:

• Immunology
• Transplantation Biology
• Human Genetics

Background:

• Bone marrow transplantation (BMT) success hinges on immune response regulation, particularly genes within the major histocompatibility complex (MHC).
• The human leukocyte antigen (HLA) system, specifically the HLA-D/DR region, plays a critical role in graft acceptance and graft-versus-host disease (GVHD).

Purpose of the Study:

• To review the theoretical and practical aspects of bone marrow transplantation.
• To detail methods for typing alleles at HLA-A, -C, -B, -DR, and complotype loci.
• To examine HLA-D typing approaches (HTC and PLT) and their limitations in specific patient populations.

Main Methods:

• Detailed consideration of HLA allele typing methods for various loci (HLA-A, -C, -B, -DR, complotype).
• Analysis of recombination, linkage disequilibrium, and extended haplotypes in populations.
• Examination of High-Resolution Typing (HTC) and Primed Lymphocyte Typing (PLT) for HLA-D typing.

Main Results:

• HLA-D/DR typing is often ambiguous in BMT candidates (e.g., aplastic anemia, leukemia, SCID), necessitating modified typing procedures.
• Complotype and GLO allele determinations in family members provide crucial additional information.
• Extended haplotypes on chromosome 6, particularly in HLA-B, -DR, complotype, and GLO regions, offer promise for identifying compatible unrelated donors.

Conclusions:

• Accurate HLA typing, including HLA-D/DR and complotype, is essential for optimizing bone marrow transplantation outcomes.
• Improved typing strategies and understanding of population genetics (extended haplotypes) can enhance the use of unrelated donors.
• Further research into methods for removing cytotoxic T cells and identifying genotypically similar individuals will increase BMT possibilities.